| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |